Want to see AU:NUC full AI Analyst Report?
NUC Stock Chart & Stats
AU$0.12
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.12
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.20
Previous CloseN/A
Volume11.15K
Average Volume (3M)2.56K
Market Cap
AU$12.55M
Enterprise ValueAU$13.77M
Total Cash (Recent Filing)AU$2.13M
Total Debt (Recent Filing)AU$4.19M
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding156,818,770
10 Day Avg. Volume281
30 Day Avg. Volume2,562
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.97
Price to Sales (P/S)0.45
P/FCF Ratio-1.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$28.30M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue more than doubled across 2021–2026, indicating meaningful demand traction and a larger operating base. Continued top-line expansion can improve fixed-cost absorption, support broader distribution, and create a foundation for future profitability if margins stabilize.
Focused Nutrition PortfolioA focused infant and children’s nutrition portfolio gives Nuchev a clearly defined category position and supports consistent product development around a specific consumer need. This concentration may help build brand recognition and deepen relevance with families over time.
Multi-Channel DistributionPresence across both retail and online channels gives the company multiple routes to reach consumers and reduces reliance on a single selling format. Maintaining this channel breadth can support customer access, product discovery, and future revenue expansion as the portfolio develops.
Bears Say
Persistent LossesNuchev has not demonstrated sustainable profitability, with operating and net losses continuing across the reported period. Ongoing losses reduce internal funding capacity, weaken resilience, and leave future growth dependent on achieving a more consistent improvement in operating economics.
Gross Margin CollapseThe sharp latest-year margin deterioration materially weakens the earnings potential of rising revenue. Unless gross margin recovers, additional sales may contribute limited profit, making it harder to cover operating costs and establish a durable path to positive earnings.
Cash Burn And LeveragePersistent negative operating and free cash flow means the core business continues consuming cash, while higher leverage reduces financial flexibility. This combination increases reliance on external funding or balance-sheet resources and raises the consequences of losses persisting.
Nuchev Pty Ltd News
NUC FAQ
What was Nuchev Pty Ltd’s price range in the past 12 months?
Nuchev Pty Ltd lowest share price was AU$0.06 and its highest was AU$0.20 in the past 12 months.
What is Nuchev Pty Ltd’s market cap?
Nuchev Pty Ltd’s market cap is AU$12.55M.
When is Nuchev Pty Ltd’s upcoming earnings report date?
Nuchev Pty Ltd’s upcoming earnings report date is Mar 01, 2027 which is in 129 days.
How were Nuchev Pty Ltd’s earnings last quarter?
Nuchev Pty Ltd released its earnings results on Aug 27, 2026. The company reported -AU$0.032 earnings per share for the quarter.
Is Nuchev Pty Ltd overvalued?
According to Wall Street analysts Nuchev Pty Ltd’s price is currently Overvalued.
Does Nuchev Pty Ltd pay dividends?
Nuchev Pty Ltd does not currently pay dividends.
What is Nuchev Pty Ltd’s EPS estimate?
Nuchev Pty Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuchev Pty Ltd have?
Nuchev Pty Ltd has 156,818,770 shares outstanding.
What happened to Nuchev Pty Ltd’s price movement after its last earnings report?
Nuchev Pty Ltd reported an EPS of -AU$0.032 in its last earnings report. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of Nuchev Pty Ltd?
Currently, no hedge funds are holding shares in AU:NUC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nuchev Pty Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.46%
12-Months-Change
Fundamentals
Return on Equity
-88.51%
Trailing 12-Months
Asset Growth
12.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nuchev Pty Ltd
Nuchev Limited functions as a specialized health and nutrition company, responsible for the production, marketing, and distribution of infant formula and various nutritional items derived from goat milk. Its products are sold to consumers across Australia, China, and Vietnam. The firm offers a range of options under its Oli6 brand, including toddler nutrition, powdered goat milk, and general health and wellness goods. These products can be purchased through both conventional retail outlets and online e-commerce platforms. Nuchev Limited was established in 2013 and maintains its corporate headquarters in Melbourne, Australia.
Technical Analysis
Noumi Limited
―
Australian Dairy Nutritionals Group
―
Bubs Australia Ltd.
―
Nutritional Growth Solutions Ltd.
―
Clover Corporation Limited
―